Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	260.45M
Revenue (ttm)	336.87M
Net Income (ttm)	6.38M
Shares Out	81.39M
EPS (ttm)	0.08
PE Ratio	40.52
Forward PE	17.78
Dividend	0.05 (1.53%)
Ex-Dividend Date	May 15, 2025

Volume	25,829
Average Volume	38,346
Open	3.200
Previous Close	3.200
Day's Range	3.110 - 3.210
52-Week Range	2.460 - 3.400
Beta	0.76
RSI	67.17
Earnings Date	Nov 5, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,437
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.